Their expression negatively correlated with advanced clinicopathological characteristics (pathological tumor stage, pathological lymph node metastasis, Gleason score, and BCR status) in PCa patients (Figs. S10C–F, S11C–F). The gene discussed is BCR; the disease is metastatic malignant neoplasm in the lymph nodes.